The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era

A Mocroft, H J Furrer, J M Miro, P Reiss, C Mussini, O Kirk, S Abgrall, S Ayayi, B Bartmeyer, D Braun, A Castagna, A d'Arminio Monforte, B Gazzard, F Gutierrez, I Hurtado, Karina Jansen, L Meyer, P Muñoz, N Obel, P Soler-PalacinA Papadopoulos, F Raffi, J T Ramos, J K Rockstroh, D Salmon, C Torti, J Warszawski, S de Wit, R Zangerle, C Fabre-Colin, J Kjaer, G Chene, J Grarup, J D Lundgren, Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

95 Citationer (Scopus)

Abstract

Few studies consider the incidence of individual AIDS-defining illnesses (ADIs) at higher CD4 counts, relevant on a population level for monitoring and resource allocation.
OriginalsprogEngelsk
TidsskriftClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Vol/bind57
Udgave nummer7
Sider (fra-til)1038-47
Antal sider10
DOI
StatusUdgivet - okt. 2013

Citationsformater